Neal Navani qualified in Medicine from Cambridge and UCL in 2000 with distinction and several University prizes. He trained in Respiratory Medicine at the Brompton and Hammersmith Hospitals before winning a Medical Research Council Fellowship in 2008 and completing his PhD at UCL in 2011. He has also completed an MSc in Clinical Trials at the London School of Hygiene and Tropical Medicine. Dr Navani was appointed as a Consultant in Thoracic Medicine at University College London Hospital in 2011.
Dr Navani is lead clinician for Lung Cancer and the tertiary diagnostic and interventional Bronchoscopy services at UCLH. He is an author of the British Thoracic Society guideline and quality standards for bronchoscopy and is on the interventional procedures specialist advisory group. He is a member of the National Cancer Research Institute lung cancer clinical studies group and chairs the Screening and Early Disease subgroup. In 2016, he took up a position as a clinical co-lead of the National Lung Cancer Audit.
Dr Navani holds an honorary contract with the MRC Clinical Trials Unit at UCL and is a Senior Lecturer at UCL. He has authored over 40 peer-reviewed publications. He is the co-author of a textbook on respiratory disorders and the Lung Cancer chapter in the Oxford Textbook of Medicine. Dr Navani also sits on the lung cancer board of London Cancer as research lead and is a peer reviewer for many journals including BMJ, ARCCM and Thorax as well as charities such as the MRC and CRUK.
Dr Navani runs several clinical trials on the diagnosis and staging of lung disease and bronchoscopic techniques. He holds honorary positions at the Medical Research Council Clinical Trials Unit and University College London and is also a member of the UCLH early lung cancer detection and surveillance programme. His research is patient focussed and aims to improve the patient experience and outcomes.
Dr Navani has authored numerous peer-reviewed publications and is the co-author of a textbook on respiratory disorders. He is an invited member of a NICE technology assessment group, the British Thoracic Society guideline development group for bronchoscopy and is a peer reviewer for many journals including Thorax.
1. Utility of endobronchial ultrasound-guided transbronchial needle aspiration in patients with tuberculous intrathoracic lymphadenopathy: a multicentre study. Navani N, Molyneaux PL, Breen RA, Connell DW, Jepson A, Nankivell M, Brown JM, Morris-Jones S, Ng B, Wickremasinghe M, Lalvani A, Rintoul RC, Santis G, Kon OM, Janes SM. Thorax. 2011 Oct;66(10):889-93.
2. Endobronchial ultrasound guided trans-bronchial needle aspiration for the diagnosis of intra-thoracic lymphadenopathy in patients with extra-thoracic malignancy: a multi-centre study. Navani N, Nankivell M, Woolhouse I, Harrison RN, Munavvar M, Oltmanns U, Falzon M, Kocjan G, Rintoul RC, Janes SM. Journal of Thoracic Oncology. 2011
3. Combining endobronchial ultrasound guided transbronchial needle aspiration with standard bronchoscopic techniques for the diagnosis of stage I and II pulmonary sarcoidosis. Navani N, Booth HL, Kocjan G, Falzon M, Capitanio A, Brown JM, Porter JC, Janes SM. Respirology. 2011; 16(3): 467-72.
4. The Learning Curve for EBUS-TBNA. Navani N, Nankivell M, Nadarajan P, Kocjan G, Pereira SP, Janes SM. Thorax. 2011; 66(4): 352-3.
5. PET Scanning is important in lung cancer; but it has its limitations. Navani N and Spiro SG. Respirology. 2010; 15(8): 1149-51
6. Inaccurate clinical nodal staging of non-small cell lung cancer: evidence from the MRC LU22 multicentre randomised trial. Navani N, Nankivell M, Stephens RJ, Parmar MK, Gilligan D, Nicolson M, Groen HJ, van Meerbeeck JP. Thorax. 2010 May;65(5):463
7. Preoperative integrated PET-CT scanning reduces the number of futile thoracotomies for lung cancer. Navani N. Thorax. 2009 Dec;64(12):1089
8. Endoscopic procedures for the diagnosis of sarcoidosis. Navani N and Shah PL. Sarcoidosis .
9. Mediastinal staging of NSCLC with endoscopic and endobronchial ultrasound. Navani N, Spiro SG, Janes SM. Nat Rev Clin Oncol. 2009; 6: 278-86
10. EBUS-TBNA for the mediastinal staging of non-small cell lung cancer. Navani N, Spiro SG, Janes SM. Journal of Thorac Oncol 2009; 776.
11. Symptoms and signs of lung cancer. Navani N and Spiro SG. Eur Resp Mon. 2009: 44: 71-87.
12. Diagnostic endoscopic procedures for lung cancer. Navani N and Janes SM. Eur Resp Mon. 2009: 44: 136-49.
13. Lung cancer staging with minimally invasive endoscopic techniques. Navani N, Janes SM, Spiro SG. JAMA. 2008 4;299(21):2509.
14. Contemporary issues in lung cancer imaging. Navani N and Janes SM. Br J Cancer 2008; 98: 855
15. A high number of transmissions of H7N7 avian influenza A virus to humans. A Lung Alert. Navani N. Thorax 2004;59;:395. Other publications:
16. Induction Chemotherapy and Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Patients with locally Advanced Inoperable Non-small-cell Lung Cancer: The MRC INCH Randomized Trial. Hatton M, Nankivell M, Lyn E, Falk S, Pugh C, Navani N, Stephens RJ, Parmar M. Int J Radiat Oncol Biol Phys. 2010 Oct 5 In Press.
17. Squamous cell cancers contain a side population of stem-like cells that are made chemosensitive by ABC transporter blockade. Loebinger MR, Giangreco A, Groot KR, Prichard L, Allen K, Simpson C, Bazley L, Navani N, Tibrewal S, Davies D, Janes SM. Br J Cancer. 2008 Jan 29;98(2):380-7.
Books and book chapters:
18. Self-assessment Text in Respiratory Medicine. Editors and Co-authors: Spiro SG, Albert R, Brown JS, Navani N. Manson Publishing, 2011.
19. Oxford Handbook of Key Clinical Evidence. Respiratory Medicine chapter. Navani N and Ind PW. Oxford University Press. 2008
20. The Multidisciplinary Management of Lung Cancer. Symptoms and signs of lung cancer. Navani N and Spiro SG. 2008